echo 2023 session 29: biomarkers for hepatocellular carcinoma (hcc)
Published 9 months ago • 388 plays • Length 56:17Download video MP4
Download video MP3
Similar videos
-
55:10
echo 2023 session 27: liver cancer surveillance
-
37:36
echo 2023 session 23: updated cdc universal screening guidelines for hepatitis b
-
39:37
echo 2024 session 32: hepatocellular carcinoma and clinical considerations for special populations.
-
28:46
echo 2023 session 22: chronic hepatitis b infection
-
58:33
webinar: ensuring those with hepatitis b are involved in guideline development
-
34:54
tratamiento de la hepatitis b
-
1:21:30
g-echo fellows presentation : hepatitis b
-
58:14
echo 2023 session 28: hepatitis b reactivation among people living with hiv
-
46:53
echo 2022 session 20: hepatitis b and current treatments in development
-
40:28
echo 2023 session 25: perinatal hepatitis b
-
31:15
echo 2023 session 21: aasld 2022 key highlights
-
8:50
hepatocellular carcinoma (hcc) screening
-
27:34
echo 2021 session 5: hepatitis b and hcc screening
-
36:28
echo 2024 session 31: hbv testing, interpretation, and treatment initiation
-
31:16
echo 2023 session 24: hepatitis delta epidemiology, virology, and treatment landscape
-
34:23
echo 2022 session 19: primary care and liver health
-
1:38
dr. el-khoueiry discusses research on biomarkers in hcc
-
37:45
echo 2024 session 30: updated who hepatitis b clinical guidelines
-
20:36
currnt and new biomakers in hbv infection - asociated hcc
-
33:19
updates in hepatocellular carcinoma - 01/23/2023
-
16:23
hcc biomarkers current and future use